Multicentric Castleman Disease and Systemic Lupus Erythematosus Phenotype in a Boy With Klinefelter Syndrome: Long-term Disease Stabilization With Interferon Therapy
- 1 March 2000
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 22 (2), 180-183
- https://doi.org/10.1097/00043426-200003000-00021
Abstract
An 11-year-old boy with Klinefelter syndrome had Castleman disease (CD) of plasma cell type develop. Nonregulated antibody production mimicked systemic lupus erythematosus (SLE). Hepatitis C virus (HCV) infection caused significant disease worsening. The patient was treated with a daily dosage of 2 million units/m2 of IFN-alpha. Dramatic clinical improvement and decreasing autoimmune phenomenon were observed. HCV RNA were cleared. Hypergammaglobulinemia did not change. The boy has been living for 8 years with his disease. Plasma cell type CD can mimic collagenosis. Disease worsening is caused by HCV, though it can be reversed with IFN-alpha. Klinefelter syndrome may be a genetic susceptibility factor for CD in some cases.Keywords
This publication has 20 references indexed in Scilit:
- Klinefelter Syndrome and Non-Hodgkin LymphomaCancer Genetics and Cytogenetics, 1997
- Autoimmune findings resembling connective tissue disease in a patient with castleman's diseaseClinical Rheumatology, 1997
- Case Report: Testosterone Treatment of Systemic Lupus Erythematosus in a Patient With Klinefelter’s SyndromeThe American Journal of the Medical Sciences, 1995
- Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [see comments]Blood, 1995
- Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcomaThe Lancet, 1995
- Hepatitis C virus infection in patients with non‐Hodgkin's lymphomaBritish Journal of Haematology, 1994
- Mixed Connective Tissue Disease associated with Multicentric Castleman's DiseaseScandinavian Journal of Rheumatology, 1994
- New Observations in a Child with Angiofollicular Lymph Node Hyperplasia (Castlemanʼs Disease) Originated from the Mesenteric RootJournal of Pediatric Hematology/Oncology, 1992
- Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's diseaseBlood, 1989
- Localized mediastinal lymph-node hyperplasia resembling thymomaCancer, 1956